Chemopreventive effects of berries and berry components in animal models: Prevention of estrogen-mediated mammary tumors in ACI rats by berries

Berries and Cancer Prevention

Volumn , Issue , 2011, Pages 163-187

  Aiyer, Harini ^a,b   Ravoori, Srivani ^a   Gupta, Ramesh ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

ACI rat model; Black raspberry; Blueberry; Ellagic acid allometric scaling; Hormonal breast cancer; Prevention

Indexed keywords

EID: 84861899846     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7554-6_9     Document Type: Chapter

References (121)

1. ACS (2007a) Breast cancer facts and figures-2007. American Cancer Society, Atlanta, GA
2. ACS (2007b) Cancer facts and figures-2007. American Cancer Society, Atlanta, GA
3. ACS (2009) Cancer Facts and Figures-2009. American Cancer Society, Atlanta, GA
4. Adamovic T, Roshani L, Chen L, Schaffer BS, Helou K, Levan G, Olsson B, Shull JD (2007) Nonrandom pattern of chromosome aberrations in 17beta-estradiol-induced rat mammary tumors: indications of distinct pathways for tumor development. Genes Chromosomes Cancer 46:459-469
5. Adams LS, Zhang Y, Seeram NP, Heber D, Chen S (2010) Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila Pa) 3:108-113
6. Afaq F, Zaman N, Khan N, Syed DN, Sarfaraz S, Zaid MA, Mukhtar H (2008) Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables. Int J Cancer 123:1508-1515
7. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF (1996) The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 17:821-828
8. Aiyer HS, Gupta RC (2010) Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev Res (Phila) 3: 727-737
9. Aiyer HS, Kichambare S, Gupta RC (2008b) Prevention of oxidative DNA damage by bioactive berry components. Nutr Cancer 60(Suppl 1):36-42
10. Aiyer HS, Li Y, Liu QH, Reuter N, Martin RC (2010) Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats. Nutrition, in press
11. Aiyer H, Ravoori S, Schultz D, Gupta RC (2008a) The effect of dietary berries and ellagic acid on cell proliferation, estrogen-metabolizing enzymes and tumor indices in an estrogen-induced rat mammary tumor model. Proceedings of the International Conference on New Developments in Drug Discovery from Natural Products and Traditional Medicines.
12. Aiyer HS, Srinivasan C, Gupta RC (2008c) Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats. Nutr Cancer 60:227-234
13. 2+-mediated activation of 4-hydroxy estradiol. Am Assoc Cancer Res 43:1146
14. Aiyer HS, Vadhanam MV, Stoyanova R, Caprio GD, Clapper ML, Gupta RC (2008d) Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genes. Int J Mol Sci 9:327-341
15. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405-412
16. Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102:680-691
17. Balfe PJ, McCann AH, Welch HM, Kerin MJ (2004) Estrogen receptor beta and breast cancer. Eur J Surg Oncol 30:1043-1050
18. Bansal S, Kausar H, Aqil F, Vadhanam M, Gupta R (2010) Polymeric implants enhance bioavail-ability of curcumin by providing a continous ("24/7") delivery system. Proc Am Assoc Cancer Res 51:Abst 1880
19. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 100:3913-3918
20. Blackshear PE (2001) Genetically engineered rodent models of mammary gland carcinogenesis: an overview. Toxicol Pathol 29:105-116
21. Blank EW, Wong PY, Lakshmanaswamy R, Guzman R, Nandi S (2008) Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats. Proc Natl Acad Sci USA 105:3527-3532
22. Boivin D, Blanchette M, Barrette S, Moghrabi A, Beliveau R (2007) Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res 27:937-948
23. Brown ML, Goldie S, Draisma G, Harford J, Lipscomb J (2006) Health service interventions for cancer control in developing countries. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (eds) Disease control in developing countries. Oxford University Press, New York, NY, pp 569-589
24. Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188:641-644
25. Cano A, Hermenegildo C (2000) The endometrial effects of SERMs. Hum Reprod Update 6: 244-254
26. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93
27. Cavalieri EL, Higginbotham S, Ramakrishna NV, Devanesan PD, Todorovic R, Rogan EG, Salmasi S (1991) Comparative dose-response tumorigenicity studies of dibenzo[alpha, l]pyrene versus 7, 12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha, l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 12: 1939-1944
28. Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N, Kansra S (2009) Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression. Am J Physiol Endocrinol Metab 297:E331-E339
29. Clarke R (1996) Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 39:1-6
30. Clarke R, Leonessa F, Welch JN, Skaar TC (2001) Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53:25-71
31. Cranney A, Adachi JD (2005) Benefit-risk assessment of raloxifene in postmenopausal osteoporosis. Drug Saf 28:721-730
32. Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM (2006) Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev 15:551-558
33. Cutts JH, Noble RL (1964) Estrone-induced Mammary Tumors in the RAT. I. Induction and behavior of tumors. Cancer Res 24:1116-1123
34. Daniel EM, Krupnick AS, Heur Y, Blinzler JA, Nims RW, Stoner GD (1989) Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J Food Compost Anal 2:338-349
35. Dickson RB, Stancel GM (2000) Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 27:135-145
36. Dunning WF, Curtis MR, Segaloff A (1947) Strain differences in response to diethylstilbes-terol and the induction of mammary gland and bladder cancer in the rat. Cancer Res 7: 511-521
37. Dunning WF, Curtis MR, Segaloff A (1953) Strain differences in response to estrone and the induction of mammary gland, adrenal, and bladder cancer in rats. Cancer Res 13:147-152
38. Fernandes I, Faria A, Azevedo J, Soares S, Calhau C, De Freitas V, Mateus N (2010) Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation. J Agric Food Chem 58:3785-3792
39. Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, Lachel CM, VanderWoude EA, Pennington KL, Flood LA, Bynote KK, Meza JL, Newton MA, Shull JD (2004) Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 168:2113-2125
40. Groves FD, Gupta RC (2009) Lead time between diagnosis and treatment of cancer in Kentucky. Soc Epidemiol Res 42:Abst 203
41. Gupta RC, Bansal SS, Aqil F, Cao P, Jeyabalan J, Russell GK, Ravoori S, Vadhanam MV (2009a) A novel concept in delivering chemopreventive compounds. Proc Am Assoc Cancer Res 50: Abst 944
42. Gupta RC, Jeyabalan J, Aqil F, Vadhanam MV, Schultz DJ, Ravoori S (2009b) Potent chemopro-tective activity of Apiaceae spices. NCI Translational Science Meeting
43. Gutmann DH, Hunter-Schaedle K, Shannon KM (2006) Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest 116:847-852
44. Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6: 213-218
45. Hao J, Zhang B, Liu B, Lee M, Hao X, Reuhl KR, Chen X, Yang CS (2009) Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model. Int J Cancer 124:1270-1275
46. Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S (2001) Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer 92:333-337
47. Holtzman S (1988) Retinyl acetate inhibits estrogen-induced mammary carcinogenesis in female ACI rats. Carcinogenesis 9:305-307
48. Holtzman S, Stone JP, Shellabarger CJ (1981) Synergism of estrogens and X-rays in mammary carcinogenesis in female ACI rats. J Natl Cancer Inst 67:455-459
49. Huggins C, Briziarelli G, Sutton H Jr (1959) Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109:25-42
50. Huggins C, Grand LC, Brillantes FP (1961) Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature 189:204-207
51. Jordan VC (2006) Optimising endocrine approaches for the chemoprevention of breast cancer beyond the study of tamoxifen and raloxifene (STAR) trial. Eur J Cancer 42:2909-2913
52. Jordan VC (2008) Tamoxifen: catalyst for the change to targeted therapy. Eur J Cancer 44:30-38
53. Kim JB, O'Hare MJ, Stein R (2004) Models of breast cancer: is merging human and animal models the future? Breast Cancer Res 6:22-30
54. Kurz SG, Hansen KK, McLaughlin MT, Shivaswamy V, Schaffer BS, Gould KA, McComb RD, Meza JL, Shull JD (2008) Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat. Endocrinology 149: 3850-3859
55. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54:1611-1620
56. Li JJ, Li SA, Klicka JK, Parsons JA, Lam LK (1983) Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 43: 5200-5204
57. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K, Ballenger J, Tawfik O, Li SA (2002a) Ploidy differences between hormone-and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33:56-65
58. Li Y, Trush MA, Yager JD (1994) DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis 15: 1421-1427
59. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 101:18123-18128
60. Li SA, Weroha SJ, Tawfik O, Li JJ (2002b) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175:297-305
61. Liehr JG (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21:40-54
62. Liehr JG (2001) Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7:273-281
63. Liehr JG, Ricci MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93:3294-3296
64. Lyle SF, Wright K, Collins DC (1984) Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats. Cancer 53:1473-1477
65. Mense SM, Singh B, Remotti F, Liu X, Bhat HK (2009) Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis 30:1202-1208
66. Mesia-Vela S, Sanchez RI, Reuhl KR, Conney AH, Kauffman FC (2006) Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August-Copenhagen Irish rat. J Pharmacol Exp Ther 317:590-597
67. Mesia-Vela S, Sanchez RI, Roberts KG, Reuhl KR, Conney AH, Kauffman FC (2008) Dietary clofibrate stimulates the formation and size of estradiol-induced breast tumors in female August-Copenhagen Irish (ACI) rats. Toxicology 246:63-72
68. Morrow M, Jordan VC (2000) Tamoxifen for the prevention of breast cancer in the high-risk woman. Ann Surg Oncol 7:67-71
69. Nguyen V, Tang J, Oroudjev E, Lee CJ, Marasigan C, Wilson L, Ayoub G (2010) Cytotoxic effects of bilberry extract on MCF7-GFP-tubulin breast cancer cells. J Med Food 13:278-285
70. *1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Res 63:8153-8157
71. Oyama T, Morita M, Isse T, Kagawa N, Nakata S, So T, Mizukami M, Ichiki Y, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K (2005) Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Front Biosci 10:1156-1161
72. Paluszczak J, Krajka-Kuzniak V, Baer-Dubowska W (2010) The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 192: 119-125
73. Papoutsi Z, Kassi E, Tsiapara A, Fokialakis N, Chrousos GP, Moutsatsou P (2005) Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta. J Agric Food Chem 53:7715-7720
74. Parkin DM (2009) Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 45:1649-1653
75. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. Ca Cancer J Clin 55:74-108
76. Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70-S80
77. Petrek JA, Sandberg WA, Cole MN, Silberman MS, Collins DC (1985) The inhibitory effect of caffeine on hormone-induced rat breast cancer. Cancer 56:1977-1981
78. Porter P (2008) "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 358:213-216
79. Powles TJ (2002) Anti-oestrogenic prevention of breast cancer-the make or break point. Nat Rev Cancer 2:787-794
80. Ravoori S, Aqil F, Gupta RC (2009) Prevention of breast cancers in rat model by berries and potential mechanisms. Am Assoc Cancer Res 50:Abst 931
81. Ravoori S, Kausar H, Aqil F, Gupta RC (2010) Distinct molecular targets of blueberry and black raspberry in breast cancer prevention. Proc Am Assoc Cancer Res 51:Abst 1887
82. Ravoori S, Vadhanam M, Kausar H, Moktar A, Vuppalapati P, Schultz D, Gupta R (2008) Effect of select berries on estrogen-induced mammary tissue proliferation. Proc Am Assoc Cancer Res 49:Abst 3821
83. Ravoori S, Vadhanam MV, Sahoo S, Srinivasan C, Gupta RC (2007) Mammary tumor induction in ACI rats exposed to low levels of 17beta-estradiol. Int J Oncol 31:113-120
84. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661
85. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244-278
86. Russo J, Russo IH (2004) Genotoxicity of steroidal estrogens. Trends Endocrinol Metab 15: 211-214
87. Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, Tochacek M, Gould KA, Meza JL, McComb RD, Shull JD (2006) Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 66:7793-7800
88. Schmitt E, Stopper H (2001) Estrogenic activity of naturally occurring anthocyanidins. Nutr Cancer 41:145-149
89. Schneider K, Oltmanns J, Hassauer M (2004) Allometric principles for interspecies extrapolation in toxicological risk assessment-empirical investigations. Regul Toxicol Pharmacol 39: 334-347
90. Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, Scheuller HS, Heber D (2006) Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem 54:9329-9339
91. Seradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96:E1-E6
92. Shepel LA, Gould MN (1999) The genetic components of susceptibility to breast cancer in the rat. Prog Exp Tumor Res 35:158-169
93. Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL (1997) Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis 18:1595-1601
94. Sims AH, Howell A, Howell SJ, Clarke RB (2007) Origins of breast cancer subtypes and therapeutic implications. Nat Clin Pract Oncol 4:516-525
95. Singh B, Mense SM, Remotti F, Liu X, Bhat HK (2009) Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J Biochem Mol Toxicol 23:202-211
96. Singletary KW, Jung KJ, Giusti M (2007) Anthocyanin-rich grape extract blocks breast cell DNA damage. J Med Food 10:244-251
97. Smith WA, Freeman JW, Gupta RC (2001) Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a, l]pyrene in the human breast cells MCF-7. Mutat Res 480-481:97-108
98. Snyderwine EG, Thorgeirsson UP, Venugopal M, Roberts-Thomson SJ (1998) Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in Sprague-Dawley rats on high-and low-fat diets. Nutr Cancer 31:160-167
99. Srinivasan P, Vadhanam MV, Arif JM, Gupta RC (2002) A rapid screening assay for antioxidant potential of natural and synthetic agents in vitro. Int J Oncol 20:983-986
100. Stoner GD, Sardo C, Apseloff G, Mullet D, Wargo W, Pound V, Singh A, Sanders J, Aziz R, Casto B, Sun X (2005) Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J Clin Pharmacol 45:1153-1164
101. Stoner GD, Dombkowski AA, Reen RK, Cukovic D, Salagrama S, Wang LS, Lechner JF (2008) Carcinogen-altered genes in rat esophagus positively modulated to normal levels of expression by both black raspberries and phenylethyl isothiocyanate. Cancer Res 68:6460-6467
102. Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, Shen F, McLaughlin MT, Pennington KL, Meza JL, Shull JD (2005) Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics 169: 2189-2197
103. Studzinski G, Harrison L (2002) Genetic Basis for the Emergence and Progression of Breast Cancer. In: Donegan WL, Spratt JS (eds) Cancer of the Breast. Saunders, Philadelphia, PA, pp 169-179
104. Thompson HJ, Adlakha H, Singh M (1992) Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1- nitrosourea. Carcinogenesis 13: 1535-1539
105. Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 125-134
106. Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9:221-236
107. Thompson HJ, McGinley J, Rothhammer K, Singh M (1998) Ovarian hormone dependence of pre-malignant and malignant mammary gland lesions induced in pre-pubertal rats by 1-methyl-1-nitrosourea. Carcinogenesis 19:383-386
108. Thompson HJ, Singh M (2000) Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 5:409-420
109. Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC, Yang J, Guzman RC, Nandi S, Talamantes F (2001) Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22:2039-2047
110. Vadhanam M, Aqil F, Bansal S, Cao P, Jeyabalan J, Ravoori S, Gupta R (2010) Controlled-release systemic delivery of chemopreventive agents-An update. Proc Am Assoc Cancer Res 51: Abst 5673
111. Vadhanam M, Ravoori S, Aqil F, Gupta R (2008) Ellagic acid administered by a novel, sustained drug-delivery system inhibits estrogen-induced mammary carcinogenicity. Proc Am Assoc Cancer Res 49:Abst 3835
112. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438
113. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170-178
114. Wada L, Ou B (2002) Antioxidant activity and phenolic content of Oregon caneberries. J Agric Food Chem 50:3495-3500
115. Warren R, Harvie M, Howell A (2004) Strategies for managing breast cancer risk after the menopause. Treat Endocrinol 3:289-307
116. Welsch CW (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415-3443
117. Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491-498
118. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54:4069-4075
119. Wu X, Prior RL (2005) Systematic identification and characterization of anthocyanins by HPLC-ESI-MS/MS in common foods in the United States: fruits and berries. J Agric Food Chem 53:2589-2599
120. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27:67-73
121. Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27